Literature DB >> 29507637

Continuous-flow retro-Diels-Alder reaction: an efficient method for the preparation of pyrimidinone derivatives.

Imane Nekkaa1, Márta Palkó1, István M Mándity1, Ferenc Fülöp1,2.   

Abstract

The syntheses of various pyrimidinones as potentially bioactive products by means of the highly controlled continuous-flow retro-Diels-Alder reaction of condensed pyrimidinone derivatives are presented. Noteworthy, the use of this approach allowed us to rapidly screen a selection of conditions and quickly confirm the viability of preparing the desired pyrimidinones in short reaction times. Yields typically higher than those published earlier using conventional batch or microwave processes were achieved.

Entities:  

Keywords:  continuous-flow; desulfurisation; norbornene-fused heterocycles; pyrimidinones; retro-Diels–Alder reaction

Year:  2018        PMID: 29507637      PMCID: PMC5815275          DOI: 10.3762/bjoc.14.20

Source DB:  PubMed          Journal:  Beilstein J Org Chem        ISSN: 1860-5397            Impact factor:   2.883


Introduction

The continuous-flow (CF) technology has gained significant importance in modern synthetic chemistry [1-3] and becomes a core technology in the pharmaceutical, agrochemical, and fine chemical industries [4-5]. The use of this technology opens a new door to a quick optimization, acceleration [6], and easy scale-up with a wide and growing range of chemical transformations in combination with an inherently safe and green nature [7-12]. Advantageously, safety issues are complied with excellent mixing and heat transfer [7-14]. These allow the access to elevated temperatures and pressures accredited to superheating of organic solvents in a controlled and safe fashion [6,14-17]. The accurate tuning of residence time can further broaden the versatility of CF processes by governing the outcome of chemical reactions, determining the reaction rate and the conversion and by influencing product selectivities [17-19]. Thus, flow chemistry has long been selected to provide a simple means to use more rigorous reaction conditions and revisit difficult reactions that have been neglected in the past [21]. The retro-Diels–Alder (rDA) reaction has become an important tool for synthetic chemists in their search towards the synthesis and design of novel heterocyclic scaffolds. This pyrolytic dissociation arises when one or both fragments are notably stable [22]. The unsaturation present in the original starting material is produced in the DA addition, and the same atoms are involved in both the bond formation and cleavage steps [23-25]. The rDA process is an efficient technique for the introduction of a double bond into a heterocyclic skeleton [26] as well as for the enantiodivergent [27] and the enantiocontrolled [28] syntheses of heterocyclic compounds. The rDA products can be gained, due to a thermal [4 + 2]-cycloreversion, by distillation under reduced pressure [29], boiling in solvent [30-31], and applying microwave irradiation [32-35] or flash vacuum pyrolysis [35-36]. rDA reactions under mild conditions have been widely examined and discussed for the laboratory preparation of heteromonocycles or condensed-ring heterocycles [37-40]. However, the CF rDA method was introduced when Meyers’ group performed the preparation of a precursor intermediate for the construction of diverse tetracycline antibiotics [41]. Our aim in the present study was to synthesize functionalized pyrimidinone systems through rDA reactions. Many of these products are of high importance in drug design due to their diverse biological properties including antimicrobial, antiviral, antioxidant and antitumor activities. In addition, they are present in several natural frameworks [42-44]. We wanted to exploit the benefits of flow processing for reaction optimization and synthesis and develop novel sustainable synthetic methodologies with possible useful applications for the pharmaceutical industry. Our results show that the developed CF technology is superior to existing conventional batch technologies.

Results and Discussion

The starting materials, i.e., fused tricyclic or tetracyclic pyrimidinones 1–8 have been previously prepared by literature methods [26,45-50]. Cyclization of the corresponding di-exo- or di-endo-amino acids or esters with ethyl p-chlorobenzimidate resulted in tricyclic pyrimidinones 1, 2a and 2b [26,45-49]. Methanopyrrolo-, methanopyrido- and methanoazepino[2,1-b]quinazolinones 3–6 were prepared by ring enlargement of di-exo-norbornene-fused azetidinones with lactim ethers [50]. For the preparation of 2-thioxopyrimidinones 7, 8a and 8b, the most common method is the reaction of the appropriate amino esters with phenyl isothiocyanate, followed by cyclization of the resulting thiourea with hydrogen chloride under reflux [45,49]. The starting materials were selected to comprise molecules where good (>80%), medium (70–80%) and no conversion was observed under batch rDA conditions. Batch reactions were carried out by the following ways: heating under neat conditions, refluxing in solvents having a high boiling point [chlorobenzene (CB) or 1,2-dichlorobenzene (DCB)], and under microwave (MW) conditions in DCB. In order to provide a rapid and efficient access to the desired pyrimidinones 9–14 (Scheme 1), we reinvestigated these rDA reactions by using another method involving flow chemistry. Therefore, a modular flow system was designed, equipped with a heated 304 stainless steel coil and an adjustable back-pressure regulator (0–300 bar) controlling the use of solvents under superheated conditions. The coil was heated in an oven to the desired temperature and solutions of the starting materials 1–8 were loaded into the reactor via a HPLC pump. Solvents were selected on the basis of the solubility of the starting materials. A schematic representation of the flow reactor setup is illustrated in Figure 1. Products 9–14 thus prepared were identified by means of HPLC–MS and NMR spectroscopic analysis. All physical and spectroscopic data of pyrimidinones 9–14 were identical with their literature data (Supporting Information File 1).
Scheme 1

Flow synthesis for the preparation of fused pyrimidinones 9–14 by rDA reaction. Solvent and conditions (FR is the flow rate): (i) MeCN, toluene, FR = 0.5 mL min−1, 230–250 °C; (ii) MeOH, FR = 0.5 mL min−1, 120–150 °C; (iii) MeCN, FR = 0.5 mL min−1, 220–250 °C.

Figure 1

Schematic outline of the continuous-flow reactor.

Flow synthesis for the preparation of fused pyrimidinones 9–14 by rDA reaction. Solvent and conditions (FR is the flow rate): (i) MeCN, toluene, FR = 0.5 mL min−1, 230–250 °C; (ii) MeOH, FR = 0.5 mL min−1, 120–150 °C; (iii) MeCN, FR = 0.5 mL min−1, 220–250 °C. Schematic outline of the continuous-flow reactor. The rDA reaction is basically a thermally-driven process. Consequently, by careful reaction parameter optimization, a balance should be found between the desired rDA cycloreversion reaction and the unwanted thermal degradation of the rDA product. The conversion and yield of a reaction under CF conditions is influenced directly by the residence time and reaction temperature, which are crucial determining factors in flow chemistry [18-20]. Thus, these two parameters were fine-tuned for all of the starting materials. The residence time was set by the use of coils with different lengths. The pressure and flow rate of the reactions were kept at constant values of 10 bars and 0.5 mL min−1, respectively. The full reaction parameter optimization is shown only for compound 1 in Table 1.
Table 1

Reaction parameter optimization for the CF rDA reaction of 1.

entrytemperature [°C]residence time [min]conversion [%]degradation product [%]

12001064
22101082
32201083
423010860
5240101007
62501010018
7230151000
82303010013
Reaction parameter optimization for the CF rDA reaction of 1. The tricyclic di-exo-2-(4-chlorophenyl)tetrahydro-5,8-methano-4(3H)-quinazoline (1) was dissolved in acetonitrile (MeCN) and first the effect of the temperature was investigated. The results show that with 10 min residence time the best conversion value (86%) was obtained at 230 °C (Table 1, entry 4). It should be noted that at higher temperature, a significant amount of degradation product was observed and a brown oil was isolated (Table 1, entries 5 and 6). To further improve the conversion, the residence time was increased by utilizing longer coils (Table 1, entries 7 and 8). It was found that complete conversion can be obtained at 15 min residence time and the desired rDA product was isolated with 92% yield (Table 1, entry 7, Table 2, entry 1). With longer residence times, again, degradation of the product was observed. Importantly, the complete reaction parameter optimization was carried out only in 105 min. The parameters of the optimized reaction conditions and related results are summarized in Table 2.
Table 2

Comparison between batch reactionsa and the CF process for the synthesis of pyrimidinones 9–14.

starting materialproductbatch reaction (lit.)CF in the present work

method: yieldc [%]solventbtemp [°C]residence time [min]yieldc [%]

19A: 85 [47]B: 56 [46]MeCN2301592
2a9B: 54 [46]C: 85 [54]2501095
2b9A: 63 [49]B: 58 [49]C: 72 [49]toluene2303093
310B: 70–80 [50]MeOH1301095
4111501097
5121201095
6131301094
714B: 80 [45]C: 89 [54]MeCN2101596
8a14B: 80 [45]2201096
8b14A: B: C: 0 [49](no rDA occurred)2503030d
8b15bEtOH/H2O = 2:12503090

Batch reactiona: Method A: reflux, CB, 12 h; Method B: performed at their melting points; Method C: MW, solvent: DCB (2a), EtOH (7), solvent-free (8b). bSolvents were selected on the basis of solubilities. cIsolated yield. dAfter column chromatography.

Comparison between batch reactionsa and the CF process for the synthesis of pyrimidinones 9–14. Batch reactiona: Method A: reflux, CB, 12 h; Method B: performed at their melting points; Method C: MW, solvent: DCB (2a), EtOH (7), solvent-free (8b). bSolvents were selected on the basis of solubilities. cIsolated yield. dAfter column chromatography. In the case of di-endo-isomer 2a, higher temperature (250 °C) but a shorter residence time was satisfactory to isolate 9 in a yield of 95%. Furthermore, we proceeded to investigate the elimination of cyclohexadiene from compound 2b. Because of solubility reasons, the solvent was changed to toluene, which is known to be compatible with high-temperature conditions [51-53]. Retrodiene product 9 was afforded with full conversion and in an excellent yield of 93%, which is higher than the maximum yield (85%) reached in our previous batch work [54]. Importantly, this result was achieved with a residence time of 30 min. Subsequently, tetracyclic methanopyrrolo-, methanopyrido- and methanoazepino[2,1-b]quinazolinones 3–6 were examined. Because of their excellent solubility, reactions were carried out in methanol (MeOH). Importantly, much milder reaction conditions gave satisfactory results. With the utilization of 120–150 °C and only 10 min residence time, full conversions and high yields (94–97%) were obtained. Lower yields were previously found (70–80%) using a batch process, even upon melting compounds 3–6 for 20 min [50]. The effect of the thioxo group on the rDA reaction was investigated too with compounds 7, 8a and 8b. In the case of 7, a yield of 96% was reached at full conversion at 210 °C in 15 min residence time. In the reaction of 8a, the di-endo isomer of 7, a slightly higher temperature was necessary, while an appropriate residence time of only 10 min was satisfactory to have 14 with 96% isolated yield. On the basis of these encouraging results, we decided to further examine the scope and limitation of the rDA reaction with the use of our CF reactor. Di-endo-3-phenyl-2-thioxohexahydro-5,8-ethanoquinazolin-4(1H)-one (8b) was selected, since this compound did not lose cyclohexadiene to form monocyclic 14 under batch and microwave conditions [49]. A solution of 8b in MeCN was treated in the heated coil reactor at 250 °C, with a residence time of 30 min. Importantly, according to the HPLC–MS analysis, compound 8b underwent thermal decomposition but only a moderate conversion (36%) was detected and 14 was isolated by means of column chromatography with a yield of 30%. This result is due to the lack of the quasi-aromatic character of the leaving cyclohexadiene, and possibly also due to the temperature limitation of our system. Surprisingly, however, we could detect traces of di-endo-3-phenyl-4a,5,8,8a-tetrahydro-5,8-ethanoquinazolin-4(3H)-one (15b), resulting from desulfurisation of 8b (Scheme 2). This observation prompted us to investigate whether desulfurisation can occur under the flow reactor conditions. In the literature, a similar desulfurisation batch reaction was performed with nickel catalysis, in ethanol (EtOH)/water (2:1) solution [55-57]. Thus, thioxo derivative 8b was dissolved in this mixture, and the CF method was repeated. Desulfurisation of 8b, at 250 °C without adding any catalytic metal, provided tricyclic 15b in good yield (90%). Most probably, the reaction was catalyzed by nickel, a component of the 304 stainless steel reactor coil [58-59]. These results also underline the importance to select appropriate solvents and tubing [60-61] for thermally driven reactions. In support of our results, tricyclic 15b was also prepared alternately: the mixture of 3-aminobicyclo[2.2.2]oct-5-ene-carboxylic acid, triethylorthoformate, aniline and acetic acid was subjected to microwave irradiation at 120 W at 80 °C for 20 min. After completion of the reaction, as monitored by TLC, 20% methanolic solution in water was added to get precipitation. The solid was filtered off and washed with water to get di-endo-3-phenyl-4a,5,8,8a-tetrahydro-5,8-ethanoquinazolin-4(3H)-one (15b). All spectroscopic data of the alternately synthesized compound were the same as those obtained by the flow chemical method. The protocol for the synthesis of 15b and the 1H and 13C NMR spectra of 15b are shown in Supporting Information File 1 of this study.
Scheme 2

Synthesis of tricyclic ethanoquinazolin-4(3H)-one 15b; (i) MeCN, FR = 0.5 mL min−1, 220–250 °C; (ii) EtOH/H2O = 2:1, FR = 0.5 mL min−1, 250 °C; (iii) MeCN, FR = 0.5 mL min−1, 250 °C.

Synthesis of tricyclic ethanoquinazolin-4(3H)-one 15b; (i) MeCN, FR = 0.5 mL min−1, 220–250 °C; (ii) EtOH/H2O = 2:1, FR = 0.5 mL min−1, 250 °C; (iii) MeCN, FR = 0.5 mL min−1, 250 °C. A further attempt was made to perform the rDA reaction with 15b at 250 °C with a residence time of 15 min in MeCN. However, the formation of 16 was not observed, that is the starting tetrahydroquinazolinone derivative 15b did not undergo a thermally driven rDA reaction (Scheme 2). Furthermore, by applying the same conditions on 14, no desulfurisation occurred and the formation of 16 was not detected either.

Conclusion

In the case of compounds 1–8, HPLC–MS measurements revealed full conversions to the desired pyrimidinones 9–14, whereas only a moderate conversion of 8b to 14 was observed. Mainly the retrodiene decomposition of compounds 1–8 occurred, since these latter possess the quasi-aromatic character, through the splitting-off of cyclopentadiene or cyclohexadiene. The stereochemistry (di-endo versus di-exo condensation) of the starting pyrimidinones 1, 2, 7 and 8 has no significant effect on the reaction yields. By using this safe, stable and scalable flow process, pyrimidinones 9–14 were afforded in high purity without the need for further purification steps. In addition, excellent yields and shorter reaction times are significant further advantages when compared to the corresponding batch processes. Moreover, the flow technology allowed the replacement of high-boiling and toxic solvents, which are commonly employed in batch process, e.g., CB or DCB, by less harmful, environmentally benign solvents such as toluene, MeCN, methanol, and ethanol. In summary, we have developed a simple flow-based method for the preparation of pyrimidinone derivatives, precursors of a series of pharmacologically active materials, through the rDA reaction. The design of the reactor enabled accurate control of both residence time and reaction temperature. CF syntheses were performed under high-temperature conditions with varied solvents. The CF reactor set-up ensured enhanced safety and afforded yields higher than those for the batch and microwave processes. These could be achieved through careful reaction parameter optimization. It is particularly true for 8b, which was unreactive under batch conditions, in contrast to a yield of 30% in CF. We envisage that this method can be readily extended to the preparation of other synthetically important building blocks requiring harsh conditions in batch methods. A simple, efficient and scalable production was implemented with a short processing time, which might open up new horizons for a potential CF industrial synthesis of heterocycles. Experimental procedures and analytical data.
  21 in total

Review 1.  Flow chemistry using milli- and microstructured reactors-from conventional to novel process windows.

Authors:  Tobias Illg; Patrick Löb; Volker Hessel
Journal:  Bioorg Med Chem       Date:  2010-04-03       Impact factor: 3.641

2.  Efficient access to new chemical space through flow--construction of druglike macrocycles through copper-surface-catalyzed azide-alkyne cycloaddition reactions.

Authors:  Andrew R Bogdan; Keith James
Journal:  Chemistry       Date:  2010-12-27       Impact factor: 5.236

Review 3.  Control and detection of chemical reactions in microfluidic systems.

Authors:  Andrew J DeMello
Journal:  Nature       Date:  2006-07-27       Impact factor: 49.962

4.  Synthesis and antiviral evaluation of 2'-C-methyl analogues of 5-alkynyl- and 6-alkylfurano- and pyrrolo[2,3-d]pyrimidine ribonucleosides.

Authors:  Piotr Januszczyk; Joanna Fogt; Jerzy Boryski; Kunisuke Izawa; Tomoyuki Onishi; Johan Neyts; Erik De Clercq
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

5.  Discovery of 2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators.

Authors:  Chuangxing Guo; Angelica Linton; Mehran Jalaie; Susan Kephart; Martha Ornelas; Mason Pairish; Samantha Greasley; Paul Richardson; Karen Maegley; Michael Hickey; John Li; Xin Wu; Xiaodong Ji; Zhi Xie
Journal:  Bioorg Med Chem Lett       Date:  2013-04-01       Impact factor: 2.823

6.  A practical, convergent route to the key precursor to the tetracycline antibiotics.

Authors:  David A Kummer; Derun Li; Amelie Dion; Andrew G Myers
Journal:  Chem Sci       Date:  2011-09       Impact factor: 9.825

7.  Harnessing the Versatility of Continuous-Flow Processes: Selective and Efficient Reactions.

Authors:  István M Mándity; Sándor B Ötvös; György Szőlősi; Ferenc Fülöp
Journal:  Chem Rec       Date:  2016-03-21       Impact factor: 6.771

8.  Highly Selective Continuous-Flow Synthesis of Potentially Bioactive Deuterated Chalcone Derivatives.

Authors:  Chi-Ting Hsieh; Sándor B Ötvös; Yang-Chang Wu; István M Mándity; Fang-Rong Chang; Ferenc Fülöp
Journal:  Chempluschem       Date:  2015-02-23       Impact factor: 2.863

9.  Synthesis and transformations of di-endo-3-aminobicyclo-[2.2.2]oct-5-ene-2-carboxylic acid derivatives.

Authors:  Márta Palkó; Pál Sohár; Ferenc Fülöp
Journal:  Molecules       Date:  2011-09-07       Impact factor: 4.411

Review 10.  Strategic Application of Residence-Time Control in Continuous-Flow Reactors.

Authors:  István M Mándity; Sándor B Ötvös; Ferenc Fülöp
Journal:  ChemistryOpen       Date:  2015-05-20       Impact factor: 2.911

View more
  3 in total

1.  Comparison of thermally actuated retro-diels-alder release groups for nanoparticle based nucleic acid delivery.

Authors:  Mohammad Abu-Laban; Raju R Kumal; Jonathan Casey; Jeff Becca; Daniel LaMaster; Carlos N Pacheco; Dan G Sykes; Lasse Jensen; Louis H Haber; Daniel J Hayes
Journal:  J Colloid Interface Sci       Date:  2018-04-24       Impact factor: 8.128

2.  Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.

Authors:  Congxing Liu; Lydia Witt; Chiara Ianes; Joachim Bischof; Marie-Thérèse Bammert; Joana Baier; Stefan Kirschner; Doris Henne-Bruns; Pengfei Xu; Marko Kornmann; Christian Peifer; Uwe Knippschild
Journal:  Int J Mol Sci       Date:  2019-12-07       Impact factor: 5.923

3.  Retro Diels Alder protocol for regioselective synthesis of novel [1,2,4]triazolo[4,3-a]pyrimidin-7(1H)-ones.

Authors:  Awad I Said; Márta Palkó; Matti Haukka; Ferenc Fülöp
Journal:  RSC Adv       Date:  2020-09-14       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.